In a filing, GeneDx Holdings Corp revealed its CHIEF FINANCIAL OFFICER Feeley Kevin unloaded Company’s shares for reported $27128.0 on Mar 03 ’25. In the deal valued at $103.94 per share,261 shares were sold. As a result of this transaction, Feeley Kevin now holds 3,906 shares worth roughly $0.38 million.
Then, Kevin Feeley bought 261 shares, generating $27,100 in total proceeds.
Before that, ICAHN SCHOOL OF MEDICINE AT MO bought 373,569 shares. GeneDx Holdings Corp shares valued at $35,799,117 were divested by the Stockholder at a price of $95.83 per share.
Wells Fargo initiated its GeneDx Holdings Corp [WGS] rating to an Equal weight in a research note published on August 28, 2024; the price target was $34. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating.
Price Performance Review of WGS
On Friday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock jump 0.76% to $98.01. Over the last five days, the stock has lost -4.71%. GeneDx Holdings Corp shares have risen nearly 27.52% since the year began. Nevertheless, the stocks have risen 1022.68% over the past one year. While a 52-week high of $115.60 was reached on 02/19/25, a 52-week low of $7.72 was recorded on 02/07/25. SMA at 50 days reached $83.08, while 200 days put it at $55.06.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 92.24, which if violated will result in even more drops to 86.48. On the upside, there is a resistance level at 101.30. A further resistance level may holdings at 104.60. The Relative Strength Index (RSI) on the 14-day chart is 55.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.30%. Stochastics %K at 56.43% indicates the stock is a holding.
